Randomised clinical trial: efficacy and safety of vonoprazan vs. lansoprazole in patients with gastric or duodenal ulcers – results from two phase 3, non‐inferiority randomised controlled trials

BACKGROUND: Vonoprazan is a new potassium‐competitive acid blocker for treatment of acid‐related diseases. AIM: To conduct two randomised‐controlled trials, to evaluate the non‐inferiority of vonoprazan vs. lansoprazole, a proton pump inhibitor, for treatment of gastric ulcer (GU) or duodenal ulcer...

Descripción completa

Detalles Bibliográficos
Autores principales: Miwa, H., Uedo, N., Watari, J., Mori, Y., Sakurai, Y., Takanami, Y., Nishimura, A., Tatsumi, T., Sakaki, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Randomised Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680291/
https://www.ncbi.nlm.nih.gov/pubmed/27891632
http://dx.doi.org/10.1111/apt.13876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680291/
https://www.ncbi.nlm.nih.gov/pubmed/27891632
http://dx.doi.org/10.1111/apt.13876

Ejemplares similares